A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia

Journal of Clinical Psychiatry

Volumn 64, Issue 2, 2003, Pages 134-143

  Brodaty, Henry ^a,f   Ames, David ^b   Snowdon, John ^c   Woodward, Michael ^g   Kirwan, Jeff ^d   Clarnette, Roger ^g   Lee, Emma ^e   Lyons, Ben ^g   Grossman, Fred ^g  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d PRINCESS MARGARET HOSPITAL   (New Zealand)

^e JANSSEN RESEARCH FOUNDATION   (Belgium)

^f PRINCE OF WALES HOSPITAL   (Australia)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; HALOPERIDOL; OXAZEPAM; PLACEBO; RISPERIDONE;

ADULT; AGED; AGGRESSION; AGITATION; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONJUNCTIVITIS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSKINESIA; EDEMA; EXTRAPYRAMIDAL SYMPTOM; FALLING; FEMALE; FEVER; GAIT DISORDER; HEADACHE; HUMAN; INFECTION; INJURY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; PURPURA; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; SKIN ULCER; SOMNOLENCE; TREMOR; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VOMITING;

EID: 0037328229     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0205     Document Type: Article

References (28)

1. Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 1997;278:1363-1371
2. Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 2000;54(suppl 5):S4-S9
3. Costa PT Jr, Williams TF, Somerfield M, et al. Clinical Practice Guideline Number 19: Recognition and Initial Assessment of Alzheimer's Disease and Related Dementias. Rockville, Md: US Dept Health Human Services, Agency for Health Care Policy and Research; 1996. AHCPR publication 97-0702
4. Finkel SI, Costa e Silva J, Cohen G, et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996;8(suppl 3):497-500
5. Finkel SI. Behavioral and psychological symptoms of dementia: a current focus for clinicians, researchers, and caregivers. J Clin Psychiatry 2001; 62(suppl 21):3-6
6. Tariot PN, Blazina L. The psychopathology of dementia. In: Morris JC, ed. Handbook of Dementing Illnesses. New York, NY: Marcel Dekker Inc; 1994:461-475
7. Hope T, Keene J, Fairburn CG, et al. Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease: a longitudinal study. Br J Psychiatry 1999;174:39-44
8. Brodaty H, Draper B, Saab D, et al. Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors. Int J Geriatr Psychiatry 2001;16:504-512
9. Snowdon J, Miller R, Vaughan R. Behavioural problems in Sydney nursing homes. Int J Geriatr Psychiatry 1996;11:535-541
10. Ferris SH, Steinberg G, Shulman E, et al. Institutionalization of Alzheimer's disease patients: reducing precipitating factors through family counseling. Home Health Care Serv Q 1987;8:23-51
11. Opie J, Rosewarne R, O'Connor DW. The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review. Aust N Z J Psychiatry 1999;33:789-799
12. Woods RT. Psychological therapies in dementia. In: Woods RT, ed. Handbook of Clinical Psychology of Ageing. 1st ed. New York, NY: John Wiley & Sons; 1996:575-600
13. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990;38:553-563
14. Salzman C. Treatment of the elderly agitated patient. J Clin Psychiatry 1987;48(5, suppl):19-22
15. Zaudig M. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia. Drug Saf 2000; 23:183-195
16. Jeste DV, Lacro JP, Bailey A, et al. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 1999;47:716-719
17. Jeste DV, Rockwell E, Harris MJ, et al. Conventional vs newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 1999;7:70-76
18. De Deyn PP, Rabheru K, Rasmussen A, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 1999;53:946-955
19. Katz IR, Jeste DV, Mintzer JE, et al, for the Risperidone Study Group. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry 1999;60:107-115
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
21. Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull 1988;24:653-659
22. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
23. Cohen-Mansfield J, Billig N. Agitated behaviors in the elderly, 1: a conceptual review. J Am Geriatr Soc 1986;34:711-721
24. Reisberg B, Auer SR, Monteiro IM. Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale. Int Psychogeriatr 1996;8(suppl 3):301-308
25. Dahlke F, Lohaus A, Gutzmann H. Reliability and clinical concepts underlying global judgments in dementia: implications for clinical research. Psychopharmacol Bull 1992;28:425-432
26. Chouinard D, Ross-Canard A, Annable L, et al. The Extrapyramidal Symptom Rating Scale. Can J Neurol Sci 1980;7:233
27. Chan WC, Lam LC, Choy CN, et al. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 2001;16:1156-1162
28. Caligiuri MR, Jeste DV, Lacro JP. Antipsychotic-induced movement disorders in the elderly: epidemiology and treatment recommendations. Drugs Aging 2000;17:363-384